A lymphokine regulates expression of alpha-1-proteinase inhibitor in human monocytes and macrophages.
Open Access
- 1 April 1986
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 77 (4) , 1207-1213
- https://doi.org/10.1172/jci112423
Abstract
Biosynthesis and secretion of alpha-1-proteinase inhibitor (alpha 1 PI) has been demonstrated in primary cultures of human mononuclear phagocytes, making it possible to study regulation of alpha 1 PI in normal (PiMM) and homozygous-deficient (PiZZ) individuals. In this study, expression of alpha 1 PI by blood monocytes, bronchoalveolar, and breast milk macrophages decreased during 1 wk in culture whereas expression of other secreted proteins increased. The addition of crude supernatants from mitogen-stimulated peripheral blood mononuclear cells to confluent monolayers of mononuclear phagocytes after 1 wk in culture resulted in a 2- to 2.5-fold increase in alpha 1 PI expression. The increase in alpha 1 PI expression was dose- and time-dependent, and involved a mechanism acting at a pretranslational level as shown by an increase in specific messenger RNA content corresponding to the increase in synthesis and secretion of alpha 1 PI. Although alpha 1 PI was expressed in native form and in forms complexed with serine protease by monocytes early in culture, it was expressed in its native form alone when monocytes were incubated with the lymphokine after 1 wk in culture. The regulating factor had the characteristics of a polypeptide and was derived from T lymphocytes, but it was not interferon-alpha, -beta, -gamma, or interleukin 2. This lymphokine also stimulated synthesis of alpha 1 PI in monocytes of homozygous-deficient PiZZ individuals, but had minimal effect on secretion, thereby increasing the intracellular accumulation of the inhibitor and exaggerating the defect in secretion of alpha 1 PI in these individuals. Regulation of mononuclear phagocyte alpha 1 PI expression by a lymphokine provides a model for further analysis of the effect of enhanced synthesis on a defect in posttranslational processing/secretion and for analysis of differential regulation of protease and inhibitor expressed in the same cells.This publication has 26 references indexed in Scilit:
- A distinct "slow" cellular pathway involving soluble mediators for the T cell-instructed induction of monocyte tissue factor activity in an allogeneic immune response.The Journal of Immunology, 1984
- Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.Journal of Clinical Investigation, 1984
- Biosynthesis in vitro of complement subcomponents C1q, C1s and C1̅ inhibitor by resting and stimulated human monocytesBiochemical Journal, 1983
- The isolation of a clone for human α 1-antitrypsin and the detection of α 1-antitrypsin in mRNA from liver and leukocytesBiochemical and Biophysical Research Communications, 1983
- The instructor cell for the human procoagulant monocyte response to bacterial lipopolysaccharide is a Leu-3a+ T cell by fluorescence-activated cell sorting.The Journal of Immunology, 1983
- Complement biosynthesis by human bronchoalveolar macrophagesClinical Immunology and Immunopathology, 1983
- ASSIGNMENT OF THE ALPHA-1-ANTITRYPSIN GENE AND A SEQUENCE-RELATED GENE TO HUMAN CHROMOSOME-14 BY MOLECULAR HYBRIDIZATION1983
- Cell surface alpha 1-protease inhibitor on human peripheral mononuclear cells in culture.The Journal of Immunology, 1982
- Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences, 1980
- Lymphocyte cooperation is required for amplification of macrophage procoagulant activity.The Journal of Experimental Medicine, 1980